Werewolf Therapeutics Announces Merger with Ambros Therapeutics; Terms Unreleased
Werewolf Therapeutics (HOWL) said it will merge with Ambros Therapeutics, triggering a strong pre-market move. No deal terms or financing details were provided, leaving valuation, dilution risk, and cash runway questions. Investors will focus on deal structure, potential synergies, and funding plans, with volatility likely until specifics are disclosed.
View signal analysis